recalcine- western pharmaceutical
farmaceutica chilena lider en el mercado chileno con presencia en latinoamerica , asi y compro laboratorios ingleses...
recalcine- western pharmaceutical's Basic Information
Industry
Pharmaceutical Manufacturing
Headquarters
Ecuador
Website
Headcount
51 - 200
recalcine- western pharmaceutical's Competitors
Bravir Industrial Ltda.
Minas Gerais, Brazil
Clearview Laser Vision Center
AbbVie
North Chicago, Illinois, United States
Medifarma
Lima, Peru
Pharm'Etude Junior
Employee Insights
Employee Function
Employee Location
recalcine- western pharmaceutical's Top Employees
Juan Rivao
Chief Financial Officer
Susana Acosta
directora tà cnica
Ramiro Guzman
Gerente DE Producto
Silvia Cifuentes
Gerente DE Ventas Institucionales
Marwa Badawy
District Manager
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.
⭐Top-ranked on G2 Crowd
🛡️GDPR compliant•Cancel anytime
✨Free credits every month!
Frequently Asked Questions Regarding recalcine- western pharmaceutical
Where is recalcine- western pharmaceutical's headquarter located?
recalcine- western pharmaceutical's headquarter are located at Ecuador.
How many employees does recalcine- western pharmaceutical have?
recalcine- western pharmaceutical has 51 - 200 employees.
What is recalcine- western pharmaceutical's official website?
recalcine- western pharmaceutical's official website is http://www.recalcine.com.cl
What industry does recalcine- western pharmaceutical belong to?
recalcine- western pharmaceutical is in the industry of Pharmaceutical Manufacturing
What does recalcine- western pharmaceutical do?
farmaceutica chilena lider en el mercado chileno con presencia en latinoamerica , asi y compro laboratorios ingleses...
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
